Tarveda Therapeutics, Inc.
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
Other Names/Subsidiaries
- Blend Therapeutics, Inc.
Latest on Tarveda Therapeutics, Inc.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Bangladesh Acquisition Adds To B
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
A year after Flagship Pioneering updated its name to reflect the firm's investments in innovation and company creation, and revealed a new $285m special opportunities fund, it announced on Dec. 20 tha
Pfizer Inc. 's former senior vice president of medicinal sciences, Tony Wood , has been appointed GlaxoSmithKline PLC 's senior vice president, platform technology and science, pharma R&D – eff